FibroGen Inc (NAS:FGEN)
$ 0.58 0.001 (0.17%) Market Cap: 58.45 Mil Enterprise Value: 48.65 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 49/100

Q2 2023 FibroGen Inc Earnings Call Transcript

Aug 07, 2023 / 09:00PM GMT
Release Date Price: $1.77 (-7.33%)
Operator

Good day, and thank you for standing by. Welcome to the FibroGen's Second Quarter 2023 Earnings Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, David DeLucia. Please go ahead.

David DeLucia

Good afternoon, everyone. Thank you for joining today to discuss our second quarter 2023 financial and business results. I'm David DeLucia, Vice President of Corporate FP&A and Investor Relations at FibroGen. Joining me on today's call are Thane Wettig, our Interim Chief Executive Officer; Juan Graham, our Chief Financial Officer; Dr. Mark Eisner, our Chief Medical Officer; Dr. John Hunter, our Chief Scientific Officer; Chris Chung, our Senior Vice President of China Operations; and Enrique Conterno, our outgoing Chief Executive Officer.

Following our prepared remarks, we will open the call to your questions. I would like to remind you that remarks made on today's call include forward-looking statements about FibroGen. Such statements may include,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot